Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 501 - 550 out of 87,106

Document Document Title
WO/2023/211896A1
Described herein are compositions and methods for generating oxygen in living eukaryotic cells, e.g., animal cells, by expressing a Cld enzyme (i.e., chlorite dismutase, chlorite O2-lyase, chlorite:O2 lyase), optionally in combination wi...  
WO/2023/212558A1
The present invention provides a composition and a method of treating and preventing biofilm formation and/or eradicating established biofilms in persistent infections, such as in chronic wounds, surgical site infections (SSIs) across mu...  
WO/2023/208994A2
The present invention concerns methods and devices for cultivating coenocytic algae and for producing cellulose, in particular microfibrillated cellulose (MFC). In one embodiment, the algae are grown on a solid substrate immersed in liqu...  
WO/2023/207565A1
A method for preparing a lactobionic acid fermentation composition on the basis of a supermolecular solvent of betaine and skincare use thereof. The method comprises: (1) preparing a supermolecular NaDES solvent of mandelic acid and beta...  
WO/2023/208970A1
To enable the use of more versatile the use of ingredients to make the substrate bed for solid-state fermentation, to produce umami- containing enzymatically active biomass: - A multi-component substrate system suitable for producing uma...  
WO/2023/208037A1
Provided are a nerolidol synthetase comprising structural domains having Pfam numbers PF01397 and PF03936, and a use thereof. The amino acid sequence of the nerolidol synthase is as shown in SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ...  
WO/2023/212726A2
Provided herein are triglyceride oil compositions enriched in 1,3-dioleoyl-2-palmitoylglycerol (OPO). Further provided herein are methods of producing non-naturally occurring triglyceride oil compositions enriched in OPO from non-natural...  
WO/2023/212354A1
The present disclosure provides compositions and methods for treating fungal infections. Disclosed here are proteins (Ait1p) that bind to TORC1 and regulate cell growth in yeast cells. These proteins and agents that bind to them may be e...  
WO/2023/212678A2
Provided herein are engineered halotolerant microorganisms that are susceptible to cell lysis upon resuspension in distilled water, the process of engineering the halotolerant microorganisms, and the uses thereof, including for the recov...  
WO/2023/202353A1
The present invention belongs to the technical field of microorganisms. Disclosed is a bifidobacterium longum CCFM1206 strain for producing sulforaphane and capable of relieving inflammation. The bifidobacterium longum CCFM1206 provided ...  
WO/2023/025936A9
The present invention is in the field of microbiology. The present application provides novel lactobacilli with inactivated regulatory sequences for manganese transporter MntH1 as well as composition comprising the bacteria. Such bacteri...  
WO/2023/204290A1
The present invention addresses the problem of providing a new acellular preparation that need not be prepared for each patient individually and can stably and inexpensively achieve a high killing effect on tumor cells. Provided is a m...  
WO/2023/202608A1
The present application relates to the technical field of biology, in particular to a beauveria bassiana strain with high ultraviolet radiation resistance as well as a directional mutagenesis method therefor and use thereof. The beauveri...  
WO/2023/204106A1
Provided herein are recombinant yeast cells (e.g., Candida boidinii strains) for use in jasmonic acid production.  
WO/2023/203011A1
The invention relates to preparation of plant-based meat analogue products with Leuconostoc carnosum. Such products can be made by inoculating a composition comprising said bacteria on plant based starting material. The invention also pr...  
WO/2023/202663A1
Provided are a polypeptide and a use thereof. Provided is a use of a polypeptide in preparation of a medication for treating and/or preventing PTSD, depression, or anxiety disorder, thereby providing a treatment strategy for PTSD, depres...  
WO/2023/205267A1
The present disclosure relates to compositions including or obtained from genetically modified bacterial host cells (e.g., E. colt) and methods for using the same for cell-free bacteriophage synthesis (CFBS). In particular, the present t...  
WO/2023/203157A1
The invention relates to a waste gas utilisation unit (4) for the utilisation of CO2-containing waste gas, in particular a waste gas utilisation unit (4) for furnace waste gas from furnaces (2) for burning carbonatic raw material, prefer...  
WO/2023/202281A1
The present invention relates to the technical field of bioengineering, and particularly, to a method for biosynthesis of NMN utilizing a genetically engineered bacterium. The genetically engineered bacterium is an Escherichia coli host ...  
WO/2023/203224A1
The present invention generally relates to the biotechnology engineering, and specifically to genetically modified methylotrophic bacteria which produce lactate. More specifically, the present invention provides a methylotrophic bacteriu...  
WO/2023/204347A1
Provided are a method for producing a mycelia composition, and a method for producing material containing the mycelia composition and beta-glucan, the method comprising the steps of: adding mushroom raw material containing beta-glucan to...  
WO/2023/204053A1
Provided herein are acetyl-CoA hydrolase (ACH) from Yarrowia lipolytica pO1f and its uses in jasmonic acid production.  
WO/2023/202122A1
Provided are a Curcuma wenyujin Y. H. Chen & C. Ling-derived curcumin synthetase, a gene, a vector, an engineered bacterium, and use thereof. The amino acid sequence of the curcumin synthetase is set forth in SEQ. ID NO. 2. The sequence ...  
WO/2023/201809A1
Provided are a transaminase mutant and use thereof, wherein the transaminase mutant is obtained by mutation of an amino acid sequence set forth in SEQ ID NO: 1, the mutation at least comprising: T291A; or the amino acid sequence of the t...  
WO/2023/167579A9
The invention relates to the Caulobacter vibrioides strain with deposit number CM-CNRG TB186, the Providencia rettgeri strain with deposit number CM-CNRG TB187, and the Bacillus pumilus strain with deposit number CM-CNRG TB188. These str...  
WO/2023/201434A1
Disclosed are novel veterinary vaccine compositions comprising a P. multocida PmSLP protein or an immunogenically equivalent portion thereof. The vaccine compositions may be used to ameliorate, treat or prevent pathogenic infections of f...  
WO/2023/204055A1
Provided herein are water forming NADH oxidases identified from Lactococcus lactis ATCC 19527 or from Bacillus subtilis 168 and their uses in jasmonic acid production.  
WO/2023/167578A9
Disclosed are a strain of Bacillus mojavensis with deposit number CM-CNRG TB191, a strain of Pseudomonas monteilii with deposit number CM-CNRG TB190, a strain of Rhizobium radiobacter with deposit number, and a strain of Bacillus vallism...  
WO/2023/204396A1
The present invention relates to high-protein microalgal biomass having excellent pepsin digestibility, a culture method and use thereof. A composition disclosed in the present invention has a high protein content, but also contains omeg...  
WO/2023/204358A1
The present invention relates to a food composition or a pharmaceutical composition for preventing or treating dementia, the composition comprising Bifidobacterium bifidum BGN4 (KCCM12754P) and Bifidobacterium longum BORI (KCCM-10492).  
WO/2023/201433A1
Disclosed are novel veterinary vaccine compositions comprising a P. multocida PmSLP protein or an immunogenically equivalent portion thereof. The vaccine compositions may be used to ameliorate, treat or prevent pathogenic infections of f...  
WO/2023/203196A1
The present disclosure provides a yeast-based nutrients rich in sterols to prevent or reduce slow and/or sluggish alcoholic fermentation and maintaining or increase the fermenting capacity of Active Dry Yeast (ADY) or Instant Dry Yeast (...  
WO/2023/200262A1
The present application relates to a method for producing lactic acid bacteria entrapped in calcium-alginate beads, lactic acid bacteria entrapped in calcium-alginate beads, produced by the method, a method for improving a production yie...  
WO/2023/199195A1
Provided is a method for producing at least one cannabinoid, the method comprising providing a cell capable of producing and secreting at least one cannabinoid; providing an organic solvent or an anion exchanger; growing the cell in a gr...  
WO/2023/199946A1
The purpose of the present invention is to provide a lipase which is mitigated with respect to the inhibition of the activity thereof by a surfactant and has a high washing effect. Provided is a lipase comprising the amino acid sequence ...  
WO/2023/199641A1
The present invention addresses the problem of providing: a cell cryopreservation liquid which can effectively inhibit mammalian cell death caused by freezing and thawing of the cells and which can effectively increase the proliferation ...  
WO/2023/198511A1
The invention relates to a fermentation process for the production of biosurfactants.  
WO/2023/199151A1
The present invention relates to an additive for animals, consisting of dehydrated, activated and ground diatomaceous earth, and to the method for obtaining said additive.  
WO/2023/200203A1
The present invention relates to a novel Lactobacillus rhamnosus KBL2290 strain and a composition comprising same, wherein the strain shows various activities such as improving intestinal flora, anti-inflammation, and strengthening intes...  
WO/2023/197093A1
Provided are preparation method and use of physical stimulation to control lysis and intracellular substance release of bacteria capable of producing bacterial cellulose. Provided is a plasmid for physically controlling bacterial lysis, ...  
WO/2023/198774A1
The invention provides a recombinant microalgal strain comprising in its genome a first modification which causes overexpression of a PSR1 gene, and optionally a further modification which reduces or eliminates expression from an endogen...  
WO/2023/199945A1
The purpose of the present invention is to provide a lipase which is mitigated with respect to the inhibition of the activity thereof by a surfactant and has a high washing effect. Provided is a lipase comprising an amino acid sequence r...  
WO/2023/197743A1
Provided is a method for improving an ability of a Bacillus species to remove red tide algae cells. Specifically, the method comprises: co-culturing the Bacillus species and a clay to improve the biomass and algae removal ability of the ...  
WO/2023/200285A1
The present invention relates to a novel composition for improving bacteriophage stability and maintaining long-term distribution storage stability of bacteriophages, the composition comprising sodium sulfate anhydrous so as to have exce...  
WO/2023/201078A1
The present invention provides for a genetically modified host cell comprising a first polypeptide capable of active transport of urea into the host cell and/or a second polypeptide capable of degrading urea into ammonia and carbon dioxi...  
WO/2023/198856A1
The invention relates to a method for producing proteins comprising the following steps: providing a culture medium containing at least one material fraction from the production of beer or another drink based on gluten-containing grain; ...  
WO/2023/200008A1
Provided is a method for producing cultured meat. Cultured meat is produced by culturing animal cells in the presence of bovine basic fibroblast growth factor (bbFGF) produced by using coryneform bacteria as expression hosts.  
WO/2023/197692A1
The present invention provides an engineered strain of yeast having mitochondrion-positioned reductive TCA pathway and efficiently producing succinic acid, a construction method therefor and use thereof, and belongs to the technical fiel...  
WO/2023/197365A1
The present invention relates to the technical field of fusion proteins. Provided are a recombinant protein carrying a target protein and autonomously entering a eukaryotic cell, a recombinant expression vector, a recombinant bacterium, ...  
WO/2023/197952A1
Provided are a yeast extract with high base and base derivative contents and a method for preparing same. The yeast extract with high base and base derivative contents provided herein comprises 20000-40000 mg/kg of bases and base derivat...  

Matches 501 - 550 out of 87,106